Company: Cybrexa Therapeutics
Job title: Associate Director of Biology
Sophia Gayle trained in Tian Xu’s lab in the Yale School of Medicine establishing forward genetic transposon technologies in human embryonic stem cells. She went on to become a Senior Research Scientist at LAM Therapeutics in Guilford, CT. At LAM, Sophia worked on the repurposing of clinical-stage drugs for rare disease and cancer indications as well as on the preclinical development of one of LAM Therapeutics’ lead compounds for Non-Hodgkin lymphoma. Currently Sophia serves as Associate Director of Biology for Cybrexa Therapeutics in New Haven, CT. At Cybrexa, Sophia assists in overseeing the preclinical development of Cybrexa’s novel tumor-targeting alphalex technology and DNA Damage Response inhibitor portfolio for solid tumor indications.
Utilizing alphalexTM to Empower New Applications and Combinations of Existing DDR Therapies 12:00 pm
day: Day Two